Contribution of the R8 substituent to the in vitro antibacterial potency of besifloxacin and comparator ophthalmic fluoroquinolones

Autor: Haas W, Sanfilippo CM, Hesje CK, Morris TW

Publikováno v: Clinical Ophthalmology, Vol 2013, Iss default, Pp 821-830 (2013)

Wolfgang Haas, Christine M Sanfilippo, Christine K Hesje, Timothy W Morris Department of Microbiology and Sterilization Sciences, Bausch + Lomb, Inc, Rochester, NY, USA Introduction: Previous work has shown that besifloxacin, an 8-chloro-fluoroquinol

Externí odkaz: https://doaj.org/article/f9762f88eb7a4c4fb3c941968679e0f2

Killing of Streptococcus pneumoniae by azithromycin, clarithromycin, erythromycin, telithromycin and gemifloxacin using drug minimum inhibitory concentrations and mutant prevention concentrations.

Autor: Blondeau JM; Department of Clinical Microbiology, Royal University Hospital and Saskatoon Health Region, University of Saskatchewan, Saskatoon, Saskatchewan, Canada; Department of Microbiology and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada; Departments of Pathology and Ophthalmology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Electronic address: joseph.blondeau@saskatoonhealthregion.ca., Shebelski SD; Department of Clinical Microbiology, Royal University Hospital and Saskatoon Health Region, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Hesje CK; Department of Microbiology and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

Publikováno v: International journal of antimicrobial agents [Int J Antimicrob Agents] 2015 Jun; Vol. 45 (6), pp. 594-9. Date of Electronic Publication: 2015 Feb 16.

Microbiological etiology and susceptibility of bacterial conjunctivitis isolates from clinical trials with ophthalmic, twice-daily besifloxacin.

Autor: Haas W; Bausch & Lomb, 1400 North Goodman St., Rochester, NY, 14609, USA, wolfgang.haas@bausch.com., Gearinger LS, Hesje CK, Sanfilippo CM, Morris TW

Publikováno v: Advances in therapy [Adv Ther] 2012 May; Vol. 29 (5), pp. 442-55. Date of Electronic Publication: 2012 May 25.

Evaluation of the effect of bacterial efflux pumps on the antibacterial activity of the novel fluoroquinolone besifloxacin.

Autor: Shinabarger DL; Micromyx LLC, 4717 Campus Drive, Kalamazoo, Michigan, USA. DLShinabarger@micromyx.com, Zurenko GE, Hesje CK, Sanfilippo CM, Morris TW, Haas W

Publikováno v: Journal of chemotherapy (Florence, Italy) [J Chemother] 2011 Apr; Vol. 23 (2), pp. 80-6.

Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from the eye.

Autor: Hesje CK; Bausch & Lomb, Inc., Rochester, New York, USA. christine.hesje@bausch.com, Sanfilippo CM, Haas W, Morris TW

Publikováno v: Current eye research [Curr Eye Res] 2011 Feb; Vol. 36 (2), pp. 94-102. Date of Electronic Publication: 2010 Dec 15.